MedTrace Logo

Optimizing Engagement in Services for First-Episode Psychosis

NCT05310838 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2026-03-18

No results posted yet for this study

Summary

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

Conditions

  • Engagement, Patient
  • First Episode Psychosis

Interventions

BEHAVIORAL

Behavioral Activation for First Episode Psychosis

Sessions will be offered weekly and dyads can complete the intervention during a 6-month period to accommodate competing demands encountered by the population.

BEHAVIORAL

Treatment As Usual

Given this condition, patients may also receive individual rehabilitation and/or group psychosocial interventions as part of typical clinic care.

Sponsors & Collaborators

  • University of Southern California

    collaborator OTHER

  • Olive View-UCLA Education & Research Institute

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • California State University, San Bernardino

    lead OTHER

Principal Investigators

  • Maria Santos, PhD · California State University, San Bernardino

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2025-12-16
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310838 on ClinicalTrials.gov